Clinical Trial

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421 and DW4421S in Healthy Adult Volunteers

Name: A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421 and DW4421S in Healthy Adult Volunteers — clinical trial record (NCT07364877)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Enrolling by Invitation Phase 1

View on ClinicalTrials.gov →

Record status

This record was last updated January 23, 2026 (before its estimated March 19, 2026 completion). Its status may not reflect the trial's current state.

Summary

Safety and pharmacokinetic characteristics evaluation of DW4421 and DW4421S

Trial Details

NCT Number	NCT07364877
Lead Sponsor	Daewon Pharmaceutical Co., Ltd.
Conditions	Healthy Adult Volunteer
Enrollment	38 participants
Start Date	2025-12-28
Primary Completion	2026-03-19 (estimated)
Study Completion	2026-05-18 (estimated)
Updated on ClinicalTrials.gov	2026-01-23